Ocugen Inc. (NASDAQ:OCGN) went down by -4.95% from its latest closing price compared to the recent 1-year high of $1.92. The company’s stock price has collected -2.07% of loss in the last five trading sessions. Press Release reported on 10/22/20 that CEO Dr. Shankar Musunuri to Discuss the Importance of Gene Therapy Strategic Partnerships at 4th Annual Gene Therapy for Rare Disorders Europe Conference
Is It Worth Investing in Ocugen Inc. (NASDAQ :OCGN) Right Now?
Plus, the 36-month beta value for OCGN is at 2.60. Opinions of the stock are interesting as 2 analysts out of 3 who provided ratings for Ocugen Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $0.85. OCGN currently public float of 121.38M and currently shorts hold a 5.03% ratio of that float. Today, the average trading volume of OCGN was 26.63M shares.
OCGN’s Market Performance
OCGN stocks went down by -2.07% for the week, with a monthly jump of 1.29% and a quarterly performance of -57.31%, while its annual performance rate touched -82.53%. The volatility ratio for the week stands at 6.12% while the volatility levels for the past 30 days are set at 6.39% for Ocugen Inc.. The simple moving average for the period of the last 20 days is -4.73% for OCGN stocks with a simple moving average of -19.27% for the last 200 days.
OCGN Trading at -13.78% from the 50-Day Moving Average
After a stumble in the market that brought OCGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.99% of loss for the given period.
Volatility was left at 6.39%, however, over the last 30 days, the volatility rate increased by 6.12%, as shares surge +2.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -45.57% lower at present.
During the last 5 trading sessions, OCGN fell by -2.07%, which changed the moving average for the period of 200-days by -50.81% in comparison to the 20-day moving average, which settled at $0.3231. In addition, Ocugen Inc. saw -40.88% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at OCGN starting from Castillo Kirsten, who purchase 75,000 shares at the price of $0.31 back on May 28. After this action, Castillo Kirsten now owns 75,000 shares of Ocugen Inc., valued at $23,498 using the latest closing price.
Musunuri Shankar, the Chief Executive Officer of Ocugen Inc., purchase 143,000 shares at $0.35 during a trade that took place back on Dec 12, which means that Musunuri Shankar is holding 406,000 shares at $50,050 based on the most recent closing price.
Stock Fundamentals for OCGN
Equity return is now at value -614.70, with -159.50 for asset returns.